Effie Tozzo

Discovery and Preclinical Profile of Saxagliptin (BMS-477118):  A Highly Potent, Long-Acting, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

David J. Augeri, Jeffrey A. Robl, David A. Betebenner et al. · Journal of Medicinal Chemistry · 2005 · 621 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue.

Peter R. Shepherd, Luigi Gnudi, Effie Tozzo et al. · Journal of Biological Chemistry · 1993 · 523 citations · Full text

Life Sciences, Endocrinology, Physiology +17

Targeted Disruption of the β3-Adrenergic Receptor Gene

Vedrana S. Susulic, Robert Frederich, Joel Lawitts et al. · Journal of Biological Chemistry · 1995 · 495 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +12

Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy

Robert W. Myers, Hong-Ping Guan, Juliann Ehrhart et al. · Science · 2017 · 344 citations

Life Sciences, Biochemistry, Pharmacology +17

Effects of a Novel Glycogen Synthase Kinase-3 Inhibitor on Insulin-Stimulated Glucose Metabolism in Zucker Diabetic Fatty (<i>fa</i>/<i>fa</i>) Rats

Gary W. Cline, Kirk W. Johnson, Werner Regittnig et al. · Diabetes · 2002 · 234 citations · Full text

Life Sciences, Biochemistry, Endocrinology +17